By MATTHEW PERRONE and NICKY FORSTER

5 takeaways from AP's report on the big backlog of uninspected drug factories

WASHINGTON (AP) — As COVID-19 swept across the globe in early 2020, the Food and Drug Administration pulled most of its safety inspectors from the field, creating a massive backlog of uninsp...

Nearly 2,000 drug plants are overdue for FDA checks after COVID delays, AP finds

WASHINGTON (AP) — Federal regulators responsible for the safety of the U.S. drug supply are still struggling to get back to where they were in 2019, before the COVID-19 pandemic upended fact...